计算溶液所需的质量、体积或浓度。
这是演示店铺,请务下单付款,避免造成你的财物损失。
为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
D113195-5g |
5g | 现货 | | |
D113195-25g |
25g | 现货 | | |
D113195-100g |
100g | 现货 | | |
D113195-500g |
500g | 现货 | | |
D113195-2.5kg |
2.5kg | 现货 | |
别名 | 杜灭芬,杜美芬,消毒宁,消毒灵,十二烷基-二甲基-2-苯氧基-乙基溴化铵 |
---|---|
英文别名 | (Dodecyldimethyl-2-phenoxyethyl)ammonium bromide |
规格或纯度 | 97% |
英文名称 | Domiphen bromide |
生化机理 | 季铵防腐剂。以剂量依赖性方式抑制HERG(与乙醚相关的基因)钾通道(IC 50 = 9nM)。 |
储存温度 | -20°C储存,充氩 |
运输条件 | 超低温冰袋运输 |
备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
产品介绍 |
无臭或微带特臭,味微苦而带皂味,极易溶于乙醇和氯仿,溶于水,在乙醚中几乎不溶。以溴代十二烷与苯氧乙基二甲胺为原料制得。常用溴化度米芬。为阳离子表面活性广谱杀菌剂,其作用在碱性中增强。 |
EC号 | 208-702-0 |
---|---|
IUPAC Name | dodecyl-dimethyl-(2-phenoxyethyl)azanium;bromide |
INCHI | InChI=1S/C22H40NO.BrH/c1-4-5-6-7-8-9-10-11-12-16-19-23(2,3)20-21-24-22-17-14-13-15-18-22;/h13-15,17-18H,4-12,16,19-21H2,1-3H3;1H/q+1;/p-1 |
InChi Key | OJIYIVCMRYCWSE-UHFFFAOYSA-M |
Canonical SMILES | CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1.[Br-] |
WGK Germany | 3 |
RTECS | BQ2030000 |
PubChem CID | 10866 |
UN Number | 2811 |
分子量 | 414.46 |
溶解性 | Soluble in ethanol, acetone, ethyl acetate, chloroform and water. Slightly soluble in benzene. |
---|---|
密度 | 0.863 |
敏感性 | 对湿度敏感 |
熔点 | 117-119°C |
象形图 |
Harmful |
---|---|
信号词 | Warning |
危险声明 |
H315: Causes skin irritation H319: Causes serious eye irritation H335: May cause respiratory irritation H302: Harmful if swallowed |
预防措施声明 | P261,P305+P351+P338,P280,P302+P352,P321,P405,P501,P264,P271,P270,P304+P340,P403+P233,P362+P364,P330,P264+P265,P301+P317,P337+P317,P332+P317,P319 |
WGK Germany | 3 |
RTECS | BQ2030000 |
个人防护装备 | dust mask type N95 (US),Eyeshields,Gloves |
输入批号以搜索COA:
1. P Goumas,G Gavalas,E Velonakis,A Rapidis,U Marselou-Kinti. (1984-09-01) [Antiseptic activity of domiphen bromide on the yeast Candida in the mouth].. Stomatologia, 41 ((5)): (249-257). [PMID:6399962] |
2. F Scaglione,G Scarpazza,E Marchi,G Biella,F Fraschini. (1983-01-01) Evaluation of domifen bromide in the treatment of acute infectious oral diseases.. International journal of clinical pharmacology research, 3 ((4)): (261-264). [PMID:6678823] |
3. Julien R G Navarro,Delphine Manchon,Frédéric Lerouge,Nicholas P Blanchard,Sophie Marotte,Yann Leverrier,Jacqueline Marvel,Frédéric Chaput,Guillaume Micouin,Ana-Maria Gabudean,Alexis Mosset,Emmanuel Cottancin,Patrice L Baldeck,Kenji Kamada,Stephane Parola. (2012-10-26) Synthesis of PEGylated gold nanostars and bipyramids for intracellular uptake.. Nanotechnology, 23 ((46)): (465602-465602). [PMID:23095344] |
4. Anneliese Müller,Kathrin Rychli,Andreas Zaiser,Cornelia Wieser,Martin Wagner,Stephan Schmitz-Esser. (2014-10-15) The Listeria monocytogenes transposon Tn6188 provides increased tolerance to various quaternary ammonium compounds and ethidium bromide.. FEMS microbiology letters, 361 ((2)): (166-173). [PMID:25312720] |
5. F Scaglione,M Coduri,R Nebuloni,F Fraschini. (1983-01-01) Activity and tolerability of domifen bromide in patients affected by acute infectious dental diseases: a double-blind placebo-controlled trial.. International journal of clinical pharmacology research, 3 ((5)): (357-361). [PMID:6381338] |
6. Lorenzo H Chen,Colleen E Price,Aaron Goerke,Ann L Lee,Pete A DePhillips. (2005-10-26) A reversed phase HPLC assay for the simultaneous quantitation of non-ionic and ionic surfactants in bioprocess intermediates.. Journal of pharmaceutical and biomedical analysis, 40 ((4)): (964-970). [PMID:16242286] |
7. Peng Gao,Yanhui Yang,Chunling Xiao,Yishuang Liu,Maoluo Gan,Yan Guan,Xueqin Hao,Jianzhou Meng,Shuang Zhou,Xiaojuan Chen,Jiafei Cui. (2012-09-15) Identification and validation of a novel lead compound targeting 4-diphosphocytidyl-2-C-methylerythritol synthetase (IspD) of mycobacteria.. European journal of pharmacology, 694 ((1-3)): (45-52). [PMID:22975264] |